These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18598878)

  • 1. [Perceptions and preventive behavior against dengue fever in Martinique].
    Setbon M; Raude J;
    Med Mal Infect; 2008 Jun; 38 Suppl 2():S78-81. PubMed ID: 18598878
    [No Abstract]   [Full Text] [Related]  

  • 2. [First case of dengue hemorrhagic fever with shock syndrome in Martinique].
    Mansuy JM; Delor R; Mehdaoui H; Elizabeth L
    Bull Soc Pathol Exot; 1996; 89(4):243-4. PubMed ID: 9053042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue vaccine.
    Simasathien S; Watanaveeradej V
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S363-77. PubMed ID: 16858980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of dengue, its prevention and control in India.
    Baruah K; Dhariwal AC
    J Indian Med Assoc; 2011 Feb; 109(2):82-6. PubMed ID: 21888168
    [No Abstract]   [Full Text] [Related]  

  • 5. Lessons raised by the major 2010 dengue epidemics in the French West Indies.
    Larrieu S; Cassadou S; Rosine J; Chappert JL; Blateau A; Ledrans M; Quénel P
    Acta Trop; 2014 Mar; 131():37-40. PubMed ID: 24315801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue in travellers is still underestimated.
    Allwinn R; Hofknecht N; Doerr HW
    Intervirology; 2008; 51(2):96-100. PubMed ID: 18477850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dengue fever climbs the social ladder.
    Nature; 2007 Aug; 448(7155):734-5. PubMed ID: 17700664
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dengue; fever, exanthema and arthralgia].
    Kager PA
    Ned Tijdschr Geneeskd; 1989 Oct; 133(40):1977-8. PubMed ID: 2812084
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant nucleocapsid-like particles from dengue-2 virus induce protective CD4+ and CD8+ cells against viral encephalitis in mice.
    Gil L; López C; Lazo L; Valdés I; Marcos E; Alonso R; Gambe A; Martín J; Romero Y; Guzmán MG; Guillén G; Hermida L
    Int Immunol; 2009 Oct; 21(10):1175-83. PubMed ID: 19692540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes.
    Ramanathan MP; Kuo YC; Selling BH; Li Q; Sardesai NY; Kim JJ; Weiner DB
    Vaccine; 2009 Oct; 27(46):6444-53. PubMed ID: 19580892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine prospects for dengue haemorrhagic fever.
    World Health Forum; 1993; 14(2):203. PubMed ID: 8185774
    [No Abstract]   [Full Text] [Related]  

  • 12. Patterns of dengue virus IgM and IgG antibodies in suspected cases of dengue in Jamaica, 2003-2006.
    Brown MG; Vickers IE; Salas RA; Smikle MF
    Hum Antibodies; 2009; 18(1-2):29-34. PubMed ID: 19478396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards a dengue vaccine: progress to date and remaining challenges.
    Guy B; Almond JW
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):239-52. PubMed ID: 17889365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tropical diseases. Hunt for dengue vaccine heats up as the disease burden grows.
    Normile D
    Science; 2007 Sep; 317(5844):1494-5. PubMed ID: 17872423
    [No Abstract]   [Full Text] [Related]  

  • 15. Deadly dengue: new vaccines promise to tackle this escalating global menace.
    Shekhar C
    Chem Biol; 2007 Aug; 14(8):871-2. PubMed ID: 17719483
    [No Abstract]   [Full Text] [Related]  

  • 16. A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge.
    De Paula SO; Lima DM; de Oliveira França RF; Gomes-Ruiz AC; da Fonseca BA
    Arch Virol; 2008; 153(12):2215-23. PubMed ID: 19002647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
    Khanam S; Pilankatta R; Khanna N; Swaminathan S
    Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin G antibody response in children and adults with acute dengue 3 infection.
    Vazquez S; Acosta N; Ruiz D; Calzada N; Alvarez AM; Guzman MG
    J Virol Methods; 2009 Jul; 159(1):6-9. PubMed ID: 19442837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue antibodies in a suburban community in Malaysia.
    Chen WS; Wong CH; Cillekens L
    Med J Malaysia; 2003 Mar; 58(1):142-3. PubMed ID: 14556343
    [No Abstract]   [Full Text] [Related]  

  • 20. Serological evidence of DEN-2 activity in Assam and Nagaland.
    Barua HC; Mahanta J
    J Commun Dis; 1996 Mar; 28(1):56-8. PubMed ID: 8778182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.